Brazil's Anvisa opens call to certify up to 8 locally made pharmaceutical ingredients

Brazil's health regulator Anvisa launched a public call to select up to eight Active Pharmaceutical Ingredients (IFAs) manufactured domestically for certification. This move aims to bolster local pharmaceutical production and reduce import dependence, though details on selection criteria and timeline remain unspecified. The initiative signals a strategic push for health-sector self-sufficiency, potentially affecting supply chains and market dynamics for drugmakers in Brazil.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works